From The New York Times:
Drug advertising will face hard scrutiny in the new Congress as it considers the renewal of fees that manufacturers pay to speed reviews of new drugs. Read the article (free with registration) here.
From The New York Times:
Drug advertising will face hard scrutiny in the new Congress as it considers the renewal of fees that manufacturers pay to speed reviews of new drugs. Read the article (free with registration) here.